CREON 1236 (Creon 180,000 units amylase / 36,000 units lipase / 114,000 units protease)
Generic Name: pancrelipase
Pill with imprint CREON 1236 is Blue / Clear, Capsule-shape and has been identified as Creon 180,000 units amylase / 36,000 units lipase / 114,000 units protease. It is supplied by AbbVie, Inc..
Creon is used in the treatment of pancreatic exocrine dysfunction; chronic pancreatitis; cystic fibrosis and belongs to the drug class digestive enzymes. Risk cannot be ruled out during pregnancy. Creon 180,000 units amylase / 36,000 units lipase / 114,000 units protease is not a controlled substance under the Controlled Substances Act (CSA).
Images for CREON 1236
Creon
- Generic Name
- pancrelipase
- Imprint
- CREON 1236
- Strength
- 180,000 units amylase / 36,000 units lipase / 114,000 units protease
- Color
- Blue / Clear
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Digestive enzymes
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- AbbVie, Inc.
- National Drug Code (NDC)
- 00032-3016
More about Creon (pancrelipase)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 35 Reviews
- Drug class: digestive enzymes
- FDA Approval History
Consumer resources
- Other brands
- Zenpep, Pertzye, Pancreaze, Viokace, ... +4 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.